| Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] |
| |
|
As of September 30, 2023
|
|
| |
|
As Previously
|
|
|
Restatement
|
|
|
|
|
|
| |
|
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Unaudited Condensed Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
27,242,000 |
|
|
|
- |
|
|
$ |
27,242,000 |
|
|
Liabilities and shareholders ’ equity (deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
10,627,000 |
|
|
|
- |
|
|
|
10,627,000 |
|
|
Preferred stock, par value $0.001 per share;
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
Common stock, par value $0.001 per share;
|
|
|
81,000 |
|
|
|
- |
|
|
|
81,000 |
|
|
Additional paid-in-capital
|
|
|
244,333,000 |
|
|
|
6,446,000 |
(1) |
|
|
250,779,000 |
|
|
Accumulated deficit
|
|
|
(227,799,000 |
) |
|
|
(6,446,000 |
)(1)
|
|
|
(234,245,000 |
) |
|
Total shareholders ’ equity (deficit)
|
|
|
16,615,000 |
|
|
|
- |
|
|
|
16,615,000 |
|
|
Total liabilities and shareholders ’ equity (deficit)
|
|
$ |
27,242,000 |
|
|
$ |
- |
|
|
$ |
27,242,000 |
|
| |
|
Three Months Ended September 30, 2023
|
|
| |
|
As Previously
|
|
|
Restatement
|
|
|
|
|
|
| |
|
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Unaudited Condensed Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss attributable to common stockholders used in computation of loss per share – basic and diluted |
|
$ |
(2,984,000 |
) |
|
$ |
(6,446,000 |
)(1)
|
|
$ |
(9,430,000 |
) |
|
Basic and diluted net loss per common share
|
|
$ |
(1.01 |
) |
|
$ |
(2.18 |
) |
|
$ |
(3.19 |
) |
|
Weighted-average number of shares outstanding, basic and diluted
|
|
|
2,957,271 |
|
|
|
2,957,271 |
|
|
|
2,957,271 |
|
| |
|
Nine Months Ended September 30, 2023
|
|
| |
|
As Previously
|
|
|
Restatement
|
|
|
|
|
|
| |
|
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Unaudited Condensed Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss attributable to common stockholders used in computation of loss per share – basic and diluted |
|
$ |
(17,056,000 |
) |
|
$ |
(6,446,000 |
)(1)
|
|
$ |
(23,502,000 |
) |
|
Basic and diluted net loss per common share
|
|
$ |
(7.44 |
) |
|
|
(2.81 |
) |
|
$ |
(10.25 |
) |
|
Weighted-average number of shares outstanding, basic and diluted
|
|
|
2,293,191 |
|
|
|
2,293,191 |
|
|
|
2,293,191 |
|
| |
|
Three and Nine Months Ended September 30, 2023
|
|
| |
|
As Previously
|
|
|
Restatement
|
|
|
|
|
|
| |
|
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Statement of Changes in Shareholders’ Equity (Deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in-capital:
|
|
$ |
244,333,000 |
|
|
$ |
6,446,000 |
(1) |
|
$ |
250,779,000 |
|
|
Accumulated Deficit:
|
|
$ |
(227,799,000 |
) |
|
$ |
(6,446,000 |
)(1)
|
|
$ |
(234,245,000 |
) |
|